ARV medication errors: Experience of a community-based HIV specialty clinic and review of the literature

Hospital Pharmacy

Volumn 42, Issue 8, 2007, Pages 720-728

  Cocohoba, Jennifer ^a   Done, Betty J ^b  

^a UCSF Medical Center and Associate Clinical UCSF School of Pharmacy   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

ARV; HIV; Medication error

Indexed keywords

ABACAVIR; ANTIRETROVIRUS AGENT; DIDANOSINE; INDINAVIR; IPRATROPIUM BROMIDE PLUS SALBUTAMOL SULFATE; LAMIVUDINE PLUS ZIDOVUDINE; LOPINAVIR PLUS RITONAVIR; RIFAMPICIN; STAVUDINE;

CLINICAL PHARMACY; COMMUNITY CARE; DOSE RESPONSE; DRUG TOLERABILITY; FEMALE; HEALTH CENTER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MEDICATION ERROR; PATIENT CARE; PRESCRIPTION; REVIEW;

EID: 34548102949     PISSN: 00185787     EISSN: None     Source Type: Journal    
DOI: 10.1310/hpj4208-720     Document Type: Review

References (20)

1. Palella FJ Jr, Delaney KM, Moorman, AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med. 1998;338:853-860.
2. Walensky RP, Paltiel AD, Losina E, et. al. The survival benefits of AIDS treatment in the United States. J Infect Dis. 2006;194:11-19.
3. Centers for Disease Control and Prevention. HIV/AIDS Surveillance Report, 2004. Vol. 16. Atlanta: US Department of Health and Human Services, Centers for Disease Control and Prevention; 2005:8. Available at: http://www.cdc.gov/hiv/ stats/hasrlink.htm. Accessed June 19, 2007.
4. US Department of Health and Human Services. The Pharmacist Workforce: A Study of the Supply and Demand for Pharmacists. HRSA National Center for Health Workforce Information and Analysis Study, 2000. Available at: http://bhpr.hrsa.gov/healthworkforce/reports/pharmacist.htm. Accessed June 19, 2007.
5. Smith SR, Golin CE, Reif S. Influence of time stress and other variables on counseling by pharmacists about ARV medications. Am J Health Syst Pharm. 2004;61:1120-1129.
6. National Coordinating Center for Medication Error Reporting and Prevention. Suggested definition of a medication error. Available at: www.nccmerp.org. Accessed June 19, 2007.
7. Fowler VG Jr, Hicks CB, Kirkland KB. The name game: lamivudine- lamotrigine dispensing error presenting as human immunodeficiency virus-associated fever of unknown origin. Int J STD AIDS. 1999;10:685-686.
8. Max B, Mourikes N. Confusion of nelfinavir and nevirapine. N Engl J Med. 1998;338:396-397.
9. Bates DW. A 40-year-old woman who noticed a medication error. JAMA. 2001;285:3134-3140.
10. Landis SJ. Azathioprine or azidothymidine? CMAJ. 1990;143:611.
11. Cohen MR. AZT: a dangerous abbreviation. Hosp Pharm. 1988;23:691.
12. Cohen MR, Davis NM. AZT is a dangerous abbreviation. Am Pharm. 1992;NS32:26.
13. Ambrosini MT, Mandler HD, Wood CA. AZT: zidovudine or azathioprine? Lancet. 1992;339:935.
14. Edelstein H, Wilson M. ARV medication errors were universal in hospitalized HIV-seropositive patients at a teaching hospital. J AIDS. 2001;28:496.
15. Purdy BD, Raymond AM, Lesar TS. ARV prescribing errors in hospitalized patients. Ann Pharmacother. 2000;34:833-838.
16. Ungvarski PJ, Rottner JE. Errors in prescribing HIV-1 protease inhibitors. J Assoc Nurses AIDS Care. 1997;8:55-61.
17. Gray J, Hicks RW, Hutchings C. ARV medication errors in a national medication error database. AIDS Patient Care STDS. 2005;19:803-812.
18. Hellinger FJ, Encinosa WE. Inappropriate drug combinations among privately insured patients with HIV disease. Med Care. 2005;43(9 suppl):III53-III62.
19. DeLorenze GN, Follansbee SF, Nguyen DP, et al. Medication error in the care of HIV/AIDS patients: electronic surveillance, confirmation, and adverse events. Med Care. 2005;43(9 suppl):III63-III68.
20. Smith RJ. Adherence to ARV HIV drugs: how many doses can you miss before resistance emerges? Proc Biol Sci. 2006;273:617-624.